The latest report by IMARC Group, titled “Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. offers a comprehensive analysis of the industry, which comprises insights on the global wearable injectors market report. The global market size reached US$ 6.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.6 Billion by 2028, exhibiting a growth rate (CAGR) of 14.8% during 2023-2028.
Wearable injectors, also known as wearable drug delivery devices, represent a significant advancement in the field of medical technology. These innovative devices are designed to provide a convenient and patient-friendly method for administering medications, particularly for chronic conditions that require frequent dosing. A wearable injector is typically worn on the patient’s body, often in the form of a patch or an easily attachable device. It incorporates a mechanism for controlled and programmable drug delivery, ensuring precise dosing at scheduled intervals. This technology is especially beneficial for individuals who require long-term treatment, such as those with diabetes, multiple sclerosis, or autoimmune disorders.
Request Your Sample Report Now: https://www.imarcgroup.com/wearable-injectors-market/requestsample
Wearable Injectors Market Trends and Drivers:
The prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and autoimmune disorders, is on the rise worldwide. Wearable injectors offer an effective means to manage these conditions by providing convenient and consistent drug administration, thus driving market growth. Additionally, there is a growing emphasis on patient-centric healthcare, with a focus on improving patient experience and outcomes. Wearable injectors empower patients to take control of their treatment, promoting adherence and reducing the need for frequent hospital visits. Other than this, the increasing use of biologics and other complex drugs necessitates precise dosing and controlled delivery. Wearable injectors are well-suited for administering these medications, further boosting their demand in the healthcare sector. In line with this, the use of wearable injectors in clinical trials is growing, as they enable precise dosing and real-time data collection. Pharmaceutical companies are increasingly adopting these devices to enhance their drug development processes. Besides this, ongoing advancements in wearable injector technology have led to more user-friendly and efficient devices. Integration with smartphone apps for monitoring and dose management adds to their appeal.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- On-body
- Off-body
Breakup by Technology:
- Spring-based
- Motor-driven
- Rotary Pump
- Expanding Battery
- Others
Breakup by Application:
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Others
Breakup by End Use:
- Hospitals and Clinics
- Home Care
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- CeQur SA
- Debiotech SA
- Dexcom Inc.
- Enable Injections Inc.
- Gerresheimer AG
- Insulet Corporation
- Tandem Diabetes Care Inc.
- West Pharmaceutical Services Inc
- Ypsomed AG.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
